We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East
Monthly Production Capacity: 1000kg
Packaging Information: 25kg/drum 1kg/bottle
Delivery Lead Time: 7 days after payment
Sample Provided: yes
Payment Terms: L/L
Product Information
Product name
Capecitabine
Molecular Formula
C15H22FN3O6
Molecular Weight
359.35
CAS No.
154361-50-9
Quality Standard
USP34, medical grade
Appearance
White powder
COA of CAPECITABINE
Items
Specifications
Results
Apperance
White or off-white crystalline powder
White crystalline powder
Identification
The spectrum of the sample corresponds to that of RS
Meets the requirements
The retention time of the major peak of the test solution corresponds to that of the RS
Meets the requirements
Specific Rotation
+96.0°~+100.0°
+98.1°
Water
≤0.3%
0.01%
Heavy Metals
≤20ppm
<20ppm
(as Pb)
Residue on ignition
≤0.1%
0.02%
Assay
98.0%~102.0%
99.70%
Usage
Function of Capecitabine
Capecitabine is rapidly absorbed through the intestinal mucosa after oral administration, and then converted into an inactive intermediate 5'-deoxy-5'fluorocytidine in the liver by carboxylesterase, and then decellularized by the liver and tumor The action of ammonia enzyme is converted into 5'-deoxy-5 'fluorouridine, and finally catalyzed by thymidine phosphorylase into fluorouracil (5-FU) in tumor tissue.
Clinical studies have shown that the concentration of 5-FU in tumor tissue after oral administration of this product is significantly higher than blood and muscle levels. The curative effect on various animal tumors is significantly higher than that of 5-FU. This product has a synergistic effect with a variety of anti-tumor drugs.
Twenty years of qualification
Audited Supplier
Pharma Sources Insight JANUARY 2024
